Politics

Greece Will Legalize Medical Cannabis

Published on July 5, 2017 · Last updated July 28, 2020

Last week, shortly after Catalonia legalized cannabis and just before the launch of Nevada’s adult-use market, the medical cannabis community in Europe welcomed another member: Greece.

At a press conference June 30, Prime Minister Alexis Tsipras and Health Minister Andreas Xanthos announced the change to the country’s Law on Control of Drugs. Tsipras said the nation is “turning its page.”

“Greece is now included in countries where the delivery of medical cannabis to patients in need is legal,” he said, according to the Greek Government Gazette. The nation joins six other European Union countries—the Czech Republic, Finland, the Netherlands, Portugal, Spain, and Germany—that have legalized the drug for medical use.

While Tsipras’s left-wing Syriza party has yet to define how cannabis would be grown or distributed under the proposal, the prime minister said cannabis would be downgraded from Table A to Table B under Greece’s regulatory structure. The move is akin to moving cannabis from a Schedule I controlled substance in the United States to Schedule II, and it recognizes the plant’s medical value in treating certain conditions.

The changes would also allow Greece to import cannabis-derived products from other medical marijuana growers, such as Canada’s licensed producers.

Greece’s Ministry of Health has identified chronic pain, neuropathic pain, nausea and vomiting due to chemotherapy, some eating disorders, and a number of other conditions as potentially legal to treat with cannabis. Back in April 2017, the ministry said it was preparing measures to allow doctors to prescribe cannabis.

Early indications are that the country will allow only cannabis edibles or extracts rather than dried flower, which is often consumed by smoking.

The legalization announcement is the latest in Greece’s slow rejection of prohibition, which has been the law of the land for decades. Recent years have seen the legalization and slow reintroduction of hemp—cannabis with less than 0.2% THC, per Greek law—as well as more organized advocacy efforts.

Friday’s change, however, was relatively unexpected, largely seen as the result of the radical-left party Syriza’s rise to power in 2015, in the wake of Greek’s economic crisis.

Kostas Skliamis, a Greek-born PhD candidate at the University of Amsterdam, and Leafly News Editor Ben Adlin contributed to this report.

Shop highly rated stores near you

Showing you stores near
See all stores
Leafly Staff
Leafly Staff
Leafly is the world’s largest cannabis information resource, empowering people in legal cannabis markets to learn about the right products for their lifestyle and wellness needs. Our team of cannabis professionals collectively share years of experience in all corners of the market, from growing and retail, to science and medicine, to data and technology.
View Leafly Staff's articles
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App Store
Download Leafly Marijuana Reviews on Google Play




The material provided on Leafly is intended for educational and informational purposes only. Leafly is not engaged in rendering medical service or advice and the information provided is not a substitute for a professional medical opinion. If you have a medical problem, please contact a qualified health professional.


© 2024 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.